To conclude, association studies in humans using methylation marks at the ABCG1 locus support a protective role for ABCG1 in CAD in the general population with methylation levels at ABCG1 CpG sites being associated with an increased risk of CHD and MI. The gene discussed is ABCG1; the disease is coronary artery disorder.